Share on Facebook Share on Twitter Share on LinkedIn Share on Google+ Share by Email

Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Glossary
    Glossary
 

Policies

2017

Australian Government Department of Health (2017)

National drug strategy 2017-2026.

Canberra: Australian Government Department of Health

The National drug strategy 2017-2026 provides a national guiding framework, which seeks to identify priorities to build safe, healthy and resilient Australian communities through preventing and minimising alcohol, tobacco and other drug related health, social and economic harms among individuals, families and communities.

This long-term framework recognises Australia's long-standing and ongoing commitment to the underpinning principle of harm minimisation and a balanced approach between health and law enforcement.

Australian Indigenous HealthInfoNet abstract

2015

Australian Department of the Prime Minister and Cabinet (2015)

National Ice Action Strategy: 2015.

Canberra: Australian Department of the Prime Minister and Cabinet

2014

Australian Department of Health (2014)

Fourth National Hepatitis C Strategy 2014-2017.

Canberra: Australian Department of Health

Australian Government Department of Health (2014)

Responding to the impact of Fetal Alcohol Spectrum Disorders in Australia: a Commonwealth action plan.

Canberra: Australian Government Department of Health

Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N (2014)

National guidelines for medication-assisted treatment of opioid dependence.

Canberra: National Drug Strategy

This document is intended to provide a broad policy context and a framework for medication-assisted treatment of opioid dependence.

It provides clinical guidelines on approaches involving the use of methadone, buprenorphine or naltrexone for the treatment of opioid dependence. It aims to provide guidance in the selection and management of patients seeking pharmacotherapies for opioid dependence, and to support the provision to patients of accurate information about methadone, buprenorphine and naltrexone.

Information includes:

  • treatment planning
  • detoxification
  • substitution treatment
  • relapse prevention: naltrexone maintenance treatment
  • good clinical practice.

This document updates and replaces four previously separate documents:

  • National pharmacotherapy policy for people dependent on opioids
  • Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence
  • National clinical guidelines and procedures for the use of buprenorphine in the maintenance treatment of opioid dependence
  • Clinical guidelines and procedures for the use of naltrexone in the management of opioid dependence.

Abstract adapted from National Drug Strategy

Intergovernmental Committee on Drugs (2014)

Framework for a national response to new psychoactive substances.

Canberra: National Drug Strategy

2013

Abhilash D, Kemp R, Ward J, Henderson S, Williams S, Smirnov A, Plotnikova M, Najman JM (2013)

Findings from the Queensland injecting drug survey (QuIDS): comparing hepatitis C risk behaviours among Indigenous and non-Indigenous people who inject drugs.

HIV Australia; 11(3): 37 - 40

Australian Government Department of Health and Ageing (2013)

National binge drinking strategy.

Retrieved 2013 from http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/cli

Australian Health Ministers’ Advisory Council (2013)

A national framework for recovery-oriented mental health services: guide for practitioners and providers.

Canberra: Department of Health and Ageing

This document is a guide for mental health practitioners and services to Australia's national framework for recovery-oriented mental health services.

The guide provides:

  • definitions for the concepts of recovery and lived experience
  • descriptions of the practice domains and key capabilities necessary for the mental health workforce to function in accordance with recovery-oriented principles
  • guidance on tailoring recovery-oriented approaches to respond to the diversity of people with mental health issues, to people in different life circumstances and at different ages and stages of life.

Abstract adapted from Australian Health Ministers’ Advisory Council

Intergovernmental Committee on Drugs (2013)

National tobacco strategy 2012-2018.

Canberra: National Drug Strategy

National Pharmaceutical Drug Misuse Framework for Action Project Team (2013)

National pharmaceutical drug misuse framework for action (2012-2015).

Canberra: Ministerial Council on Drug Strategy

2011

Ministerial Council on Drug Strategy (2011)

National drug strategy 2010-2015.

Canberra: Australian Government

The National drug strategy 2010-2015 is a framework for action on alcohol, tobacco and other drugs.

The aim of the National drug strategy 2010-2015 is to build safe and healthy communities by minimising alcohol, tobacco and other drug-related health, social and economic harms among individuals, families and communities.

The National drug strategy 2010-2015 is divided into three parts:

  • Part 1 provides background and explains the conceptual framework of the strategy
  • Part 2 details specific objectives and suggested actions under each pillar
  • Part 3 discusses the supporting approaches of workforce, evidence, performance monitoring and governance.

Abstract adapted from the National drug strategy

2010

Australian Department of Health and Ageing (2010)

National hepatitis B strategy 2010 - 2013.

: Australian Department of Health and Ageing

Department of Health and Ageing (2010)

National needle and syringe programs strategic framework 2010-2014.

Canberra: Department of Health and Ageing, Australia

2008

Australian Department of Health and Ageing (2008)

Petrol sniffing prevention program.

Retrieved 27 October, 2008 from http://webarchive.nla.gov.au/gov/20070911113010/http://www.healthconnect.gov.au/internet/wcms/publishing.nsf/Content/health-oatsih-programs-petrol

Australian National Council on Drugs (2008)

National corrections drug strategy 2006-2009.

Canberra: Australian National Council on Drugs

National Drug Strategy (2008)

National amphetamine-type stimulant strategy: 2008-2011.

Canberra: National Drug Strategy

2006

Intergovernmental Committee on Drugs (2006)

National Alcohol Strategy 2006 - 2011.

Canberra: Ministerial Council on Drug Strategy

Ministerial Council on Drug Strategy (2006)

National Alcohol Strategy 2006-2009: towards safer drinking cultures.

Canberra: Ministerial Council on Drug Strategy

Ministerial Council on Drug Strategy (2006)

National cannabis strategy 2006-2009.

Canberra: Ministerial Council on Drug Strategy

2005

Department of Health and Ageing (2005)

National hepatitis C strategy 2005-2008.

Canberra: Department of Health and Ageing

2004

Ministerial Council on Drug Strategy (2004)

The National Drug Strategy: Australia's integrated framework 2004-2009.

Canberra: Ministerial Council on Drug Strategy

The National drug strategy 2004-2009 provided a framework for a coordinated, integrated approach to drug issues in the Australian community. It has been superceded by The National drug strategy 2010-2015.

Australian Indigenous HealthInfoNet abstract

2001

Ministerial Council on Drug Strategy (2001)

National heroin overdose strategy.

Canberra: Department of Health and Aged Care


This policy has been replaced by the National guidelines for medication-assisted treatment of opioid dependence (2014).

Australian Indigenous HealthInfoNet abstract

1993

National Drug Strategy Committee (1993)

National drug strategic plan 1993-97.

Canberra: National Drug Strategy Committee

 
Last updated: 12 October 2017
 
Return to top
spacing
general box

Contribute

Share your information » Give us feedback »
spacing
 
spacing
 


Australia's National Research Centre on AOD Workforce Development National Drug and Alcohol Research Centre National Drug Research Institute